Marta Pratcorona

2.5k total citations
29 papers, 1.0k citations indexed

About

Marta Pratcorona is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marta Pratcorona has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Marta Pratcorona's work include Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). Marta Pratcorona is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). Marta Pratcorona collaborates with scholars based in Spain, Netherlands and United States. Marta Pratcorona's co-authors include Peter J.M. Valk, Claudia Erpelinck-Verschueren, Bob Löwenberg, Saman Abbas, Jordi Esteve, Marina Díaz‐Beyá, Jorge Sierra, Josep Nomdedéu, Salut Brunet and Mar Tormo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marta Pratcorona

28 papers receiving 998 citations

Peers

Countries citing papers authored by Marta Pratcorona

Since Specialization

Citations

This map shows the geographic impact of Marta Pratcorona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Pratcorona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Pratcorona more than expected).

Fields of papers citing papers by Marta Pratcorona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Pratcorona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Pratcorona. The network helps show where Marta Pratcorona may publish in the future.

Co-authorship network of co-authors of Marta Pratcorona

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Pratcorona. A scholar is included among the top collaborators of Marta Pratcorona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Pratcorona. Marta Pratcorona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases 2025 ·Diagnostic Pathology ·(unknown), (unknown), (unknown), Núria González, Francesca Guijarro, (unknown), Marta Pratcorona, Ignasi Gich, (unknown), Júlia Perera‐Bel, Lurdes Zamora, (unknown), Antònia Sampol, Antoni García‐Guiñón, Susana Vives, Mar Tormo, Montserrat Arnán, Neus Villamor, Josep Nomdedéu	0
2	Association of Clonal Hematopoiesis and Dysgranulopoiesis with Germline ETV6 Carriers without Hematological Malignancies 2024 ·Blood ·(unknown), (unknown), M L Subirá, Pamela Acha, (unknown), Marta Pratcorona, (unknown), David Valcárcel, Andrés Jerez, María Julia Montoro	1
3	Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort 2023 ·Blood Cancer Journal ·(unknown), Marta Pratcorona, Ana Garrido, (unknown), Álex Bataller, Mar Tormo, Montserrat Arnán, Susana Vives, Rosa Coll, Olga Salamero, Ferran Vall‐Llovera, Antònia Sampol, (unknown), Marta Cervera, (unknown), Joan Bargay, Xavier Ortı́n, Josep Nomdedéu, Jordi Esteve, Jorge Sierra, (unknown)	9
4	Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1 2021 ·Blood Advances ·(unknown), Álex Bataller, Ana Garrido, Montserrat Hoyos, Montserrat Arnán, Susana Vives, Rosa Coll, Mar Tormo, Antònia Sampol, Lourdes Escoda, Olga Salamero, (unknown), Joan Bargay, (unknown), Josep Nomdedéu, Jordi Esteve, Jorge Sierra, Marta Pratcorona	19
5	The evolution of hematopoietic cells under cancer therapy 2021 ·Nature Communications ·Oriol Pich, (unknown), Ferran Muiños, Marta Pratcorona, Abel González-Pérez, Núria López-Bigas	31
6	Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature 2021 ·Journal of Medical Case Reports ·(unknown), Silvana Novelli, Anna Mozos, Marta Pratcorona, Rodrigo Martino, Jorge Sierra	7
7	Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies) 2020 ·Annals of Hematology ·Elena Bussaglia, Marta Pratcorona, (unknown), Laura San‐Segundo, Miguel A. Rubio, (unknown), (unknown), Isabel Badell, Jordi Esteve, Montserrat Arnán, Carme Talarn, Mar Tormo, (unknown), Ferran Vall‐Llovera, Xavier Ortı́n, Carme Pedro, Joan Bargay, Salut Brunet, Jorge Sierra, Josep Nomdedéu	5
8	Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients 2019 ·European Journal Of Haematology ·(unknown), Ana Garrido, (unknown), Elena Bussaglia, Marta Pratcorona, (unknown), Ignasi Gich, Montserrat Hoyos, Albert Esquirol, Irene García‐Cadenas, Salut Brunet, Rodrigo Martino, Jorge Sierra, Josep Nomdedéu	6
9	Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: Case report 2019 ·SHILAP Revista de lepidopterología ·Anna Bosch, (unknown), (unknown), (unknown), Elena Bussaglia, (unknown), Ángel F. Remacha, (unknown), Marta Pratcorona, (unknown), Josep Nomdedéu	2
10	A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia 2018 ·Leukemia & lymphoma ·Montserrat Torrebadell, Marina Díaz‐Beyá, Susana G. Kalko, Marta Pratcorona, Josep Nomdedéu, Alfons Navarro, Bernat Gel, Salut Brunet, Jorge Sierra, Mireia Camós, Jordi Esteve	16
11	Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target 2017 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), Meritxell Nomdedéu, (unknown), Marta Pratcorona, Marina Díaz‐Beyá, Jordi Esteve, Ruth M. Risueño	15
12	Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value 2017 ·Biology of Blood and Marrow Transplantation ·Josep Nomdedéu, Albert Esquirol, (unknown), Marta Pratcorona, Montserrat Hoyos, Ana Garrido, Miguel A. Rubio, Elena Bussaglia, Irene García‐Cadenas, Camino Estivill, Salut Brunet, Rodrigo Martino, Jorge Sierra	30
13	Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma 2015 ·Cancer Cell International ·Meritxell Nomdedéu, (unknown), (unknown), (unknown), Marta Pratcorona, Marina Díaz‐Beyá, Xavier Calvo, Marı́a Rozman, Dolors Costa, Jordi Esteve, Ruth M. Risueño	4
14	Exploring the Expression Profile of Long Non-Coding RNA (lncRNA) in Different Acute Myeloid Leukemia (AML) Subtypes: t(8;16)(p11;p13)/MYST3-Crebbp AML Harbors a Distinctive Lncrna Signature 2015 ·Blood ·Marina Díaz‐Beyá, Alfons Navarro, Anna Cordeiro, Marta Pratcorona, Joan J. Castellano, (unknown), Meritxell Nomdedéu, Ruth M. Risueño, Marı́a Rozman, Mariano Monzó, Jordi Esteve	2
15	Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols 2015 ·Cancer ·Jordi Ribera, Mireia Morgades, Lurdes Zamora, Pau Montesinos, Inés Gómez‐Seguí, Marta Pratcorona, Josep Sarrà, Ramón Guàrdia, Josep Nomdedéu, Mar Tormo, Joaquín Martínez‐López, Jesús María Hernández‐Rivas, José González‐Campos, Pere Barba, Lourdes Escoda, Eulàlia Genescà, Françesc Solé, Fuensanta Millá, Evarist Feliú, Josep‐María Ribera, (unknown)	36
16	MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia 2013 ·Leukemia ·Marina Díaz‐Beyá, Salut Brunet, Josep Nomdedéu, Rut Tejero, Tania Díaz, Marta Pratcorona, Mar Tormo, Josep‐María Ribera, Lourdes Escoda, Rafael F. Duarte, David Gallardo, Inmaculada Heras, Maria Paz Queipo De Llano, Joan Bargay, Mariano Monzó, Jorge Sierra, Alfons Navarro, Jordi Esteve, (unknown)	47
17	Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene 2012 ·Leukemia ·Marina Díaz‐Beyá, Alfons Navarro, Gerardo Ferrer, Tania Díaz, Bernat Gel, Mireia Camós, Marta Pratcorona, Montserrat Torrebadell, Marı́a Rozman, Dolors Colomer, Mariano Monzó, Jordi Esteve	40
18	Refining the Diagnosis and Prognostic Categorization of Acute Myeloid Leukemia Patients with an Integrated Use of Cytogenetic and Molecular Studies 2012 ·Acta Haematologica ·Dolors Costa, (unknown), Ana Carrió, (unknown), (unknown), (unknown), (unknown), Dolors Colomer, Marı́a Rozman, Marta Pratcorona, Montserrat Torrebadell, Marina Díaz‐Beyá, Jordi Esteve, Elı́as Campo	1
19	Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value 2011 ·Haematologica ·Marta Pratcorona, Sakina Abbas, Matthew A. Sanders, Jasper Koenders, (unknown), Claudia Erpelinck-Verschueren, (unknown), Bob Löwenberg, Peter J.M. Valk	123
20	NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern 2011 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters, Marta Pratcorona, Saman Abbas, (unknown), (unknown), H. Berna Beverloo, Edwin Sonneveld, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Martin Zimmermann, Ursula Creutzig, Dirk Reinhardt, Rob Pieters, Peter J.M. Valk, C. Michel Zwaan	193

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact